UBS Raises Morgan Stanley to Buy with $196 Target, 18% Upside
Analysts at UBS upgraded Morgan Stanley to Buy from Neutral, setting a $196 12-month price target implying 18% upside and forecasting 2026 EPS of $11.75 and 2027 EPS of $12.60. They cited best-in-class profitability, wealth management momentum, advisory strength, large IPO pipeline and AI evolution as key catalysts.
1. UBS Upgrades Rating
Analysts at UBS raised Morgan Stanley’s rating from Neutral to Buy, setting a 12-month price target of $196 that implies roughly 18% upside. They also projected earnings per share of $11.75 for 2026 and $12.60 for 2027 to support the upgrade.
2. Profitability and Wealth Management Strength
UBS highlighted Morgan Stanley’s best-in-class profitability, noting that conservative wealth management profitability targets could be exceeded by accelerating net new asset growth driven by active capital markets.
3. Growth Catalysts and AI
Key catalysts include sustained advisory service momentum, the prospect of large IPO deals, strategic acquisitions such as E*TRADE, and the bank’s capacity to capitalize on artificial intelligence advancements within its wealth division.
4. Valuation and Regulatory Dynamics
UBS argued that while Morgan Stanley’s valuation may not appear inexpensive on traditional metrics, its underlying performance justifies a premium and suggested that industry-wide deregulation benefits are not yet fully reflected in the share price compared to peers.